Producing better antiviral peptide vaccines

Natural viral proteins cannot constantly be used as optimal vaccines because they do not always stimulate efficiently the immune system. In December 1 Journal of Clinical Investigation, Jeffrey Ahlers and colleagues from National Institutes of Health, Bethesda, USA, show that sequence modification of natural viral proteins to increase epitope affinity for class II MHC molecules (epitope enhancement) can improve immunogenicity.Ahlers et al. found that modification of a Th cell epitope to increase

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Natural viral proteins cannot constantly be used as optimal vaccines because they do not always stimulate efficiently the immune system. In December 1 Journal of Clinical Investigation, Jeffrey Ahlers and colleagues from National Institutes of Health, Bethesda, USA, show that sequence modification of natural viral proteins to increase epitope affinity for class II MHC molecules (epitope enhancement) can improve immunogenicity.

Ahlers et al. found that modification of a Th cell epitope to increase binding to MHC causes quantitatively more T cells to undergo upregulation of CD40 ligant. This induced more polarizing antigen presenting cells that act back on the T helper cell to produce a Th1-polarized response, as well as higher levels of cytotoxic T lymphocytes and protection against viral infection (J Clin Invest 2001, 108:1677-1685).

"If such enhanced epitopes can be shown to activate costimulatory pathways and to increase Th1 polarization in other settings, this work could provide an ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Tudor Toma

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo
Sapio Sciences logo

Sapio Sciences Introduces Biorepository Management Solution